Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone

J Cancer Res Clin Oncol. 1985;109(1):78-81. doi: 10.1007/BF01884259.

Abstract

The achievable concentrations of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl-3-nitrosourea (ACNU), adriamycin, mitomycin C, vindesine, and epipodophyllotoxin suppressed the natural killer (NK) activity of human peripheral blood lymphocytes in vitro, whereas NK activity was not decreased 24 h after incubation with the maximum achievable concentration of cisplatin (cDDP). NK activity of patients treated with 80 mg per square meter of cDDP alone was not decreased for 3 weeks after cDDP administration. In contrast, NK activity of patients treated with the same dose of cDDP and methylprednisolone was significantly decreased 1 week after cDDP administration. It was concluded that methylprednisolone, used as an antiemetic agent, had an immunosuppressive effect.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cisplatin / therapeutic use*
  • Cytotoxicity Tests, Immunologic
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Immune Tolerance / drug effects*
  • In Vitro Techniques
  • Killer Cells, Natural / drug effects*
  • Killer Cells, Natural / immunology
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / immunology*
  • Male
  • Mediastinal Neoplasms / drug therapy
  • Mediastinal Neoplasms / immunology*
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Mitomycin
  • Mitomycins / administration & dosage
  • Nimustine
  • Nitrosourea Compounds / administration & dosage
  • Vinblastine / administration & dosage
  • Vinblastine / analogs & derivatives
  • Vindesine

Substances

  • Antineoplastic Agents
  • Mitomycins
  • Nitrosourea Compounds
  • Nimustine
  • Mitomycin
  • Vinblastine
  • Etoposide
  • Doxorubicin
  • Cisplatin
  • Vindesine
  • Methylprednisolone